Early Infant HIV Treatment in Botswana (EIT)
BHP Early Infant Treatment Study: A Clinical Treatment Trial of HIV+ Infants in Botswana
Sponsor: Botswana Harvard Health Partnership
This PHASE2/PHASE3 trial investigates HIV and Pediatric AIDS and is currently ongoing. Botswana Harvard Health Partnership leads this study, which shows 14 recorded versions since 2015 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
14 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting PHASE2/PHASE3
-
Jan 2025 — Feb 2026 [monthly]
Active Not Recruiting PHASE2/PHASE3
-
Sep 2024 — Jan 2025 [monthly]
Active Not Recruiting PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Dec 2023 — Jul 2024 [monthly]
Active Not Recruiting PHASE2_PHASE3
▶ Show 9 earlier versions
-
Nov 2022 — Dec 2023 [monthly]
Active Not Recruiting PHASE2_PHASE3
-
Mar 2022 — Nov 2022 [monthly]
Active Not Recruiting PHASE2_PHASE3
-
Sep 2021 — Mar 2022 [monthly]
Active Not Recruiting PHASE2_PHASE3
-
Jun 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE2_PHASE3
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Jun 2021 [monthly]
Recruiting PHASE2_PHASE3
-
Aug 2020 — Jan 2021 [monthly]
Recruiting PHASE2_PHASE3
-
Mar 2019 — Aug 2020 [monthly]
Recruiting PHASE2_PHASE3
-
Jun 2018 — Mar 2019 [monthly]
Recruiting PHASE2_PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE2_PHASE3
First recorded
May 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Botswana Harvard Health Partnership
- Brigham and Women's Hospital
- Harvard School of Public Health (HSPH)
- Ragon Institute of MGH, MIT and Harvard
- University of California, San Diego
For direct contact, visit the study record on ClinicalTrials.gov .